Evaluation of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating osteocalcin undercarboxylated.

摘要

The invention relates to a method for checking the fragile bones and determination of osteoporotic fracture risk THAT IS DEFINED BY: NA SAMPLE OF BIOLOGICAL FLUID SUCH AS serum, plasma or urine; Carboxylated in the test sample with the concentration of a control sample CONTAINING carboxylated osteocalcin levels REPRESENTING THE UPPER LIMIT BAND NORMAL, concentrations above this limit SUPERIOR ARE INDICATIVE OF INCREASED RISK OF FRACTURE IN THE BONES.